Unlocking NATURE potential
Harnessing AI and nature to redefine the pace of drug discovery, uncovering bioactive compounds with unprecedented precision and speed.
Our Story / Our Technology / Impact / Our Partners /
Our Story / Our Technology / Impact / Our Partners /
Our Story / Our Technology / Impact / Our Partners
Our Story
Nature has always been humanity’s greatest teacher, and for us, it is deeply woven into our history, culture, and daily life. For centuries, the healing power of plants has been a cornerstone of wellness across generations in Asia.
At NYB, we honor this legacy by uniting centuries of cultural wisdom with groundbreaking innovation. Leveraging state-of-the-art AI technologies and scientific expertise, we uncover nature’s hidden treasures—bioactive compounds that hold the potential to transform billions of lives.
At NYB, we honor this legacy by uniting centuries of cultural wisdom with groundbreaking innovation. Leveraging state-of-the-art AI technologies and scientific expertise, we uncover nature’s hidden treasures—bioactive compounds that hold the potential to transform billions of lives.
Our Techonology
Building on this heritage, we developed DTIGN—our proprietary Drug-Target Interaction Graph Neural Network. DTIGN represents the future of drug discovery by simulating molecular interactions at the atomic level, enabling unparalleled identification of bioactive compounds with transformative potential.
Our Techonology
By blending nature’s insights with advanced technology, we accelerate the discovery of compounds that power the next generation of health and wellness products.
Impact
2B+
compound library
64x
higher hit rates than the most popular docking software
10,000+
compounds screened
44.83%
increase in bioactivity prediction efficiency
Our Partner
To us, partnership means possibility. We work closely with visionary organizations to uncover groundbreaking solutions from nature’s untapped potential. By integrating our advanced AI capabilities with the expertise and goals of our partners, we accelerate bioactive compound discovery beyond industry standards.
Featured news
Company
Nanyang Biologics at GITEX ASIA SINGAPORE 2025
Nanyang Biologics will be joining GITEX ASIA – Asia’s largest and most global tech, startup, and digital investment event – taking place from April 23 to 25 at Marina Bay Sands, Singapore.
Partnership
Nanyang Biologics Joins NVIDIA GTC 2025: Advancing AI in Drug Discovery
Nanyang Biologics is revolutionizing drug discovery with AI at NVIDIA GTC 2025! Discover how we’re using the latest technologies to accelerate life-saving innovations.
Company
Unlocking Nature’s Potential for Breakthrough Therapies with DTIGN
Nanyang Biologics' AI-driven DTIGN platform revolutionizes natural compound drug discovery with great accuracy, efficiency, and speed, unlocking nature's vast therapeutic potential for breakthrough treatments.
